| David R Clark, PA-C | |
|
1942 Braeburn Cir, Salem, VA 24153-7388 | |
| (540) 444-1240 | |
| Not Available |
| Full Name | David R Clark |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 10 Years |
| Location | 1942 Braeburn Cir, Salem, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194113464 | NPI | - | NPPES |
| 1194113464 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 0110-004821 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lewisgale Medical Center | Salem, VA | Hospital |
| Lewisgale Hospital Montgomery | Blacksburg, VA | Hospital |
| Lewisgale Hospital Alleghany | Low moor, VA | Hospital |
| Lewisgale Hospital Pulaski | Pulaski, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lewis Gale Physicians Llc | 6507886231 | 211 |
News Archive
New research on contraceptive prevalence and unmet need for contraception in married or co-habiting women of reproductive age (15 – 49 years), based on data from 194 countries, suggests that although the proportion of women in this group using contraception has risen in the last two decades, and unmet need has fallen, 233 million married or co-habiting women are projected to have an unmet need for modern contraceptive methods by 2015.
Researchers at the University of Michigan Comprehensive Cancer Center have identified a potential target to treat an aggressive type of prostate cancer. The target, a gene called SPINK1, could be to prostate cancer what HER2 has become for breast cancer.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a recent "refuse to file" (RTF) letter issued by the Food and Drug Administration (FDA) regarding Merck Serono's oral cladribine has heightened the competition between oral cladribine and its primary competitor, Novartis/Mitsubishi Tanabe's FTY-720 (fingolimod), to be the first oral disease-modifying multiple sclerosis therapy to reach the market in the United States.
Medical research charity Arthritis Research UK has awarded £250,000 to a team of researchers at the University of Bristol and the University of Aberdeen to study which genes can lead to people developing painful and common osteoarthritis of the hip.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David R Clark, PA-C 6136 Peters Creek Rd, Roanoke, VA 24019-4028 Ph: (540) 283-3660 | David R Clark, PA-C 1942 Braeburn Cir, Salem, VA 24153-7388 Ph: (540) 444-1240 |
News Archive
New research on contraceptive prevalence and unmet need for contraception in married or co-habiting women of reproductive age (15 – 49 years), based on data from 194 countries, suggests that although the proportion of women in this group using contraception has risen in the last two decades, and unmet need has fallen, 233 million married or co-habiting women are projected to have an unmet need for modern contraceptive methods by 2015.
Researchers at the University of Michigan Comprehensive Cancer Center have identified a potential target to treat an aggressive type of prostate cancer. The target, a gene called SPINK1, could be to prostate cancer what HER2 has become for breast cancer.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a recent "refuse to file" (RTF) letter issued by the Food and Drug Administration (FDA) regarding Merck Serono's oral cladribine has heightened the competition between oral cladribine and its primary competitor, Novartis/Mitsubishi Tanabe's FTY-720 (fingolimod), to be the first oral disease-modifying multiple sclerosis therapy to reach the market in the United States.
Medical research charity Arthritis Research UK has awarded £250,000 to a team of researchers at the University of Bristol and the University of Aberdeen to study which genes can lead to people developing painful and common osteoarthritis of the hip.
› Verified 8 days ago
Portia S Tomlinson, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463 | |
Mr. Paul Ashley Yeaman, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463 Fax: 540-983-1057 | |
Mr. Andrew Thomas Tokarsky, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463 | |
Mrs. Kaitlin Scott Daniels, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 100 Knotbreak Rd, Salem, VA 24153 Phone: 540-444-5670 Fax: 540-444-5669 | |
Amy Betterton, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463 | |
Anna Coffey Morris, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463 | |
Adam Lunnie, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1900 Electric Rd, Salem, VA 24153 Phone: 540-776-4970 |